Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC ( (GB:HLN) ) has issued an update.
Haleon PLC announced the purchase of 2,062,463 ordinary shares for cancellation as part of its ongoing share buyback program. This transaction is part of the second tranche of the program, initially announced in July 2025, and reflects the company’s strategic efforts to manage its capital structure. Following this purchase, the company’s registered share capital consists of 8,959,221,411 ordinary shares, with 8,955,341,206 shares having voting rights. This move is likely to impact Haleon’s market positioning by potentially increasing shareholder value and reflects a commitment to returning capital to shareholders.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £400.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.
Haleon PLC’s overall stock score reflects its strong financial performance and robust cash flow management, which are offset by technical indicators suggesting potential bearish momentum. The company faces challenges in North America, but its strategic focus on innovation and geographic growth supports a positive outlook. Valuation is moderate, offering a balanced risk-reward profile.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a diverse product portfolio across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Some of its well-known brands are Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 20,392,811
Technical Sentiment Signal: Hold
Current Market Cap: £32.5B
See more data about HLN stock on TipRanks’ Stock Analysis page.